Compounding Omnicell Patient Care 
Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Omnicell
JANUARY 10, 2023
Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Read more about the Omnicell-AHN Partnership in this week’s press release.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.
Omnicell
JANUARY 10, 2023
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Studies have shown that one out of every ten can put patients at risk. Insourcing IV compounding services at Moses H. 5 at 2 p.m.
Omnicell
JANUARY 10, 2023
Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.
Omnicell
JANUARY 10, 2023
Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.
Omnicell
SEPTEMBER 5, 2022
Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., Tools that relieve the pressures of diversion will give these teams more time to focus on patient care during these challenging times.
Expert insights. Personalized for you.
52 
Let's personalize your content